Breakthrough Cartilage Repair Treatment Closes $6.5 Million Funding Round

New York, Thursday, 18 June 2026.
A biomedical firm just secured $6.5 million to fast-track FDA approval for GelrinC, a revolutionary hydrogel implant that could transform knee cartilage repair. With no off-the-shelf treatment currently available for 470,000 annual U.S. cases, this innovation could disrupt a $5 billion global market—if clinical trials succeed.